Targeted Cancer Treatment: Plus Therapeutics CEO Marc Hedrick, Live from NYSE
Healthcare Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Healthcare Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Tech Edge hosted a fireside chat from the floor of the New York Stock Exchange...
In an interview with Cheddar TV’s Kristen Scholer, Tech Edge Editor-in-Chief John Jannarone provided tips on navigating IPOs...
By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA) is set to feature its precision sleep apnea...
By Tech Edge Editorial Qualtrics’ “Complaints and Grievances” solution for the healthcare industry will help...
By Karen E. Roman The Federal Communications Commission (FCC) is assessing the potential threat of...
By Daniella Parra Sparrow Pharmaceuticals expanded its Phase 2 clinical trial for SPI-62 in combination...
By Tech Edge Editorial MongoDB (Nasdaq: MDB), a data platform player company, reported total revenue...
By Daniella Parra Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company specializing in advanced...
By Daniella Parra Plus Therapeutics, Inc. (Nasdaq: PSTV) has expanded its partnership with Biocept with...